New: OSPS Version 12 → PBPK-QSP Modeling with MoBi®

Female Reproductive Tract (M05-12)


Description
This course aims to learn how to extend a physiologically-based pharmacokinetic (PBPK) model with the female reproductive tract extension module.
Content
  • Info: Course Goal
  • PBPK Model of a Female in PK-Sim®
  • Info: Metronidazole
  • Expression Profiles: CYP2A6 & CYP3A4
  • Individual: Woman
  • Compound: Metronidazole
  • Administration Protocol: Metronidazole IV 500 mg
  • Simulation: Metronidazole IV 500 mg (20 min)
  • Catch-Up Point 1
  • Export the Simulation from PK-Sim to MoBi®
  • PBPK model extension for FRT in MoBi®
  • Info: Female Reproductive Tract (FRT)
  • Info: PBPK Model Structure of the Female Reproductive Tract
  • Extension Module: Female Reproductive Tract
  • Parameter Values: Diffusion Coefficient & Fraction Unionized
  • Initial Conditions: Female Reproductive Tract
  • Observed Data: Female Reproductive Tract
  • Simulation: Female Reproductive Tract
  • Catch-Up Point 2
  • Local administration in the FRT in MoBi®
  • Info: Female Reproductive Tract Administration Routes
  • Extension Module: Cervicovaginal Administration
  • Parameter Values: Zero Order Process
  • Observed Data: Cervicovaginal Administration
  • Simulation: Cervicovaginal Administration
  • Final Overview
  • The End
  • Brief Course Evaluation
Completion rules
  • All units must be completed
  • Leads to a certificate with a duration: Forever